These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2171415)

  • 1. [Efficacy and long-term tolerance of ketoconazole in the treatment of Cushing's disease].
    Tabarin A; Navarranne A; Corcuff B; Guerin J; Kern AM; Roger P
    Ann Endocrinol (Paris); 1990; 51(1):27-32. PubMed ID: 2171415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of ketoconazole in the treatment of Cushing's syndrome.
    Loli P; Berselli ME; Tagliaferri M
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1365-71. PubMed ID: 3023421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of Cushing's disease using ketoconazole. Possibility of therapeutic escape].
    Diop SN; Warnet A; Duet M; Firmin C; Mosse A; Lubetzki J
    Presse Med; 1989 Sep 2-9; 18(27):1325-8. PubMed ID: 2552430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different therapeutic efficacy of ketoconazole in patients with Cushing's syndrome.
    Engelhardt D; Jacob K; Doerr HG
    Klin Wochenschr; 1989 Feb; 67(4):241-7. PubMed ID: 2538676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged treatment of Cushing's disease by ketoconazole.
    Sonino N; Boscaro M; Merola G; Mantero F
    J Clin Endocrinol Metab; 1985 Oct; 61(4):718-22. PubMed ID: 4031015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Short term effects of ketoconazole in Cushing's syndrome].
    Cerdas S; Billaud L; Guilhaume B; Laudat MH; Bertagna X; Luton JP
    Ann Endocrinol (Paris); 1989; 50(6):489-96. PubMed ID: 2699787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketoconazole treatment in Cushing's disease. Effect on the circadian profile of plasma ACTH and cortisol.
    Terzolo M; Panarelli M; Piovesan A; Torta M; Paccotti P; Angeli A
    J Endocrinol Invest; 1988 Nov; 11(10):717-21. PubMed ID: 2852693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of the treatment of Cushing's syndrome using ketoconazole].
    Conget JI; Halperin I; Vendrell J; Ferrer J; Martínez-Osaba MJ; Esmatjes E; Vilardell E
    Med Clin (Barc); 1989 Nov; 93(14):531-4. PubMed ID: 2695699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketoconazole treatment in Cushing's syndrome: experience in 34 patients.
    Sonino N; Boscaro M; Paoletta A; Mantero F; Ziliotto D
    Clin Endocrinol (Oxf); 1991 Oct; 35(4):347-52. PubMed ID: 1752063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of Cushing's syndrome with aminoglutethimide and ketoconazole.
    Kong HL; Lee KO; Cheah JS
    Singapore Med J; 1992 Oct; 33(5):523-4. PubMed ID: 1455284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of hypercortisolism control on high blood pressure in Cushing's syndrome.
    Gómez RM; Albiger NM; Díaz AG; Moncet D; Pitoia FA; Bruno OD
    Medicina (B Aires); 2007; 67(5):439-44. PubMed ID: 18051226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of levoketoconazole in the treatment of endogenous Cushing's syndrome (SONICS): a phase 3, multicentre, open-label, single-arm trial.
    Fleseriu M; Pivonello R; Elenkova A; Salvatori R; Auchus RJ; Feelders RA; Geer EB; Greenman Y; Witek P; Cohen F; Biller BMK
    Lancet Diabetes Endocrinol; 2019 Nov; 7(11):855-865. PubMed ID: 31542384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ketoconazole in pre-operative treatment in Cushing's syndrome: three cases report.
    Li KL; Tung SC; Wang PW
    Changgeng Yi Xue Za Zhi; 1996 Dec; 19(4):358-63. PubMed ID: 9041768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketoconazole. Use in the treatment of ectopic adrenocorticotropic hormone production and Cushing's syndrome in small-cell lung cancer.
    Shepherd FA; Hoffert B; Evans WK; Emery G; Trachtenberg J
    Arch Intern Med; 1985 May; 145(5):863-4. PubMed ID: 2986567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of Cushing's syndrome with steroid biosynthesis inhibitors.
    Engelhardt D; Weber MM
    J Steroid Biochem Mol Biol; 1994 Jun; 49(4-6):261-7. PubMed ID: 8043488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of ketoconazole in the treatment of residual or recurrent Cushing's disease.
    Chou SC; Lin JD
    Endocr J; 2000 Aug; 47(4):401-6. PubMed ID: 11075720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of ketoconazole in the treatment of Cushing's disease and ectopic ACTH syndrome.
    Tabarin A; Navarranne A; Guérin J; Corcuff JB; Parneix M; Roger P
    Clin Endocrinol (Oxf); 1991 Jan; 34(1):63-9. PubMed ID: 2004474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased long-term remission after adequate medical cortisol suppression therapy as presurgical treatment in Cushing's disease.
    van den Bosch OF; Stades AM; Zelissen PM
    Clin Endocrinol (Oxf); 2014 Feb; 80(2):184-90. PubMed ID: 23841642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole in the treatment of Cushing's disease.
    Dash RJ; Khandekar S; Lata V; Bhansali A
    J Assoc Physicians India; 1990 Jul; 38(7):486-9. PubMed ID: 2292555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.